metastatic cutaneous squamous cell carcinoma (CSCC)cemiplimabEmory UniversityIRB00115160
…Background Cemiplimab was approved for treatment of metastatic cutaneous squamous cell carcinoma (CSCC) based on the EMPOWER-CSCC-1 trial. A phase II study of 79 patie…